These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3587729)

  • 61. Antimicrobial effect of clindamycin in combination with aztreonam or aminoglycosides against Klebsiella spp.
    Baltch AL; Smith RP; Hammer MC; Conroy JV; Michelsen PB
    J Antimicrob Chemother; 1991 Mar; 27(3):303-10. PubMed ID: 2037536
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Aztreonam in the therapy of severe gram-negative infections.
    Davies A; Stone J; Hassan A; Quarty P; Green T
    Chemioterapia; 1987 Jun; 6(2 Suppl):389-90. PubMed ID: 3509455
    [No Abstract]   [Full Text] [Related]  

  • 63. [In vitro activity of aztreonam, cefoperazone and ceftriaxone against gram-negative bacteria].
    Baykal M; Hasçelik G
    Mikrobiyol Bul; 1990 Jul; 24(3):248-50. PubMed ID: 2283976
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Compared evaluation of The "in vitro" activity of some aminoglicosides with semi-automatic method (author's transl)].
    Cavalcanti P; Mancini V; Cannataro AM; Filia M; Greco LM
    Ann Sclavo; 1980; 22(1):83-91. PubMed ID: 7247488
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Carumonam: antibacterial activity in vitro].
    Garlaschi ML; Lombardi A; Castiglioni G; Abbiati R; Varotto F
    G Ital Chemioter; 1991; 38(1-3):185-7. PubMed ID: 1365586
    [No Abstract]   [Full Text] [Related]  

  • 66. [Increase in the frequency of norfloxacin and ciprofloxacin resistance of bacteria isolated from urine culture].
    Lopes AA; Salgado K; Martinelli R; Rocha H
    Rev Assoc Med Bras (1992); 1998; 44(3):196-200. PubMed ID: 9755547
    [TBL] [Abstract][Full Text] [Related]  

  • 67. In-vitro evaluation of carumonam (Ro 17-2301).
    Stobberingh EE; Houben AW; van Boven CP
    J Antimicrob Chemother; 1986 Sep; 18(3):345-50. PubMed ID: 3490467
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Enhanced susceptibility of gram-negative bacteria to phagocytic killing by human polymorphonuclear leucocytes after brief exposure to aztreonam.
    Pruul H; Lewis G; McDonald PJ
    J Antimicrob Chemother; 1988 Nov; 22(5):675-86. PubMed ID: 3209526
    [TBL] [Abstract][Full Text] [Related]  

  • 69. In vitro activity of aztreonam against Pseudomonas: epidemiological aspects.
    Crotti D; Barbieri C; Cellie P; Fonzo G; Visintin F
    Chemioterapia; 1987 Jun; 6(2 Suppl):107-8. PubMed ID: 3509364
    [No Abstract]   [Full Text] [Related]  

  • 70. The susceptibility of recently isolates of gram-negative bacteria to amikacin and other aminoglycosides.
    Lexomboon U; Duangmani C; Srimunta C
    J Med Assoc Thai; 1979 Oct; 62(10):544-9. PubMed ID: 501262
    [No Abstract]   [Full Text] [Related]  

  • 71. Comparison of the in vitro susceptibility of rifaximin versus norfloxacin against multidrug resistant bacteria in a hospital setting. A proof-of-concept study for use in advanced cirrhosis.
    Ramos JM; Vidal I; Bellot P; Gómez-Hurtado I; Zapater P; Such J
    Gut; 2016 Jan; 65(1):182-3. PubMed ID: 25832107
    [No Abstract]   [Full Text] [Related]  

  • 72. Sensitivity of hospital strains to amikacin.
    Kedzia W; Mirkska I; Zawieja M
    Chemioterapia; 1987 Jun; 6(2 Suppl):121-2. PubMed ID: 3509367
    [No Abstract]   [Full Text] [Related]  

  • 73. In-vitro susceptibility to aztreonam.
    Lim VK
    Malays J Pathol; 1988 Aug; 10():61-4. PubMed ID: 3252078
    [No Abstract]   [Full Text] [Related]  

  • 74. Aztreonam: the first monobactam antibiotic.
    Stutman HR
    Pediatr Infect Dis J; 1987 Jun; 6(6):550-5. PubMed ID: 3302907
    [No Abstract]   [Full Text] [Related]  

  • 75. Isolation and survey of antibiotic sensitivity in nosocomial infections in north Maharashtra region.
    Patil A; Patil K; Pawar P; Maheshwari V
    J Assoc Physicians India; 2013 Jul; 61(7):454-8. PubMed ID: 24772747
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Aztreonam.
    Outman WR
    Conn Med; 1987 Sep; 51(9):611-3. PubMed ID: 3311617
    [No Abstract]   [Full Text] [Related]  

  • 77. Gram-negative bacteria from the camel tick Hyalomma dromedarii (Ixodidae) and the chicken tick Argas persicus (Argasidae) and their antibiotic sensitivities.
    Montasser AA
    J Egypt Soc Parasitol; 2005 Apr; 35(1):95-106. PubMed ID: 15880998
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Antibacterial mechanisms of synthetic monobactams against gram-negative bacilli].
    Mitsui K
    Hiroshima Daigaku Shigaku Zasshi; 1987 Dec; 19(2):373-90. PubMed ID: 3504872
    [No Abstract]   [Full Text] [Related]  

  • 79. Serious interpretive error among three commercial systems for susceptibility testing of aztreonam. Aztreonam Study Group.
    Marshall SA
    Diagn Microbiol Infect Dis; 1995 Jul; 22(3):249-51. PubMed ID: 8565412
    [No Abstract]   [Full Text] [Related]  

  • 80. Resistance-pattern-analysis--a step toward predictable differentiated antibiotic therapy.
    Fegeler W; Lintz D; Ritzerfeld W
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Nov; 270(1-2):153-9. PubMed ID: 3223135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.